Compare BCPC & WH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCPC | WH |
|---|---|---|
| Founded | 1967 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Hotels/Resorts |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.3B |
| IPO Year | 1995 | 2017 |
| Metric | BCPC | WH |
|---|---|---|
| Price | $166.63 | $79.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $176.00 | $92.33 |
| AVG Volume (30 Days) | 137.2K | ★ 1.1M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | 0.58% | ★ 2.13% |
| EPS Growth | ★ 20.87 | N/A |
| EPS | ★ 4.75 | 2.50 |
| Revenue | $799,023,000.00 | ★ $1,429,000,000.00 |
| Revenue This Year | $8.47 | $6.65 |
| Revenue Next Year | $4.89 | $5.84 |
| P/E Ratio | $35.04 | ★ $32.29 |
| Revenue Growth | ★ 13.56 | 1.49 |
| 52 Week Low | $139.17 | $69.21 |
| 52 Week High | $183.90 | $92.69 |
| Indicator | BCPC | WH |
|---|---|---|
| Relative Strength Index (RSI) | 43.30 | 53.14 |
| Support Level | $165.89 | $78.58 |
| Resistance Level | $171.32 | $82.13 |
| Average True Range (ATR) | 4.02 | 2.17 |
| MACD | -0.41 | 0.35 |
| Stochastic Oscillator | 44.14 | 73.87 |
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
As of June 30, 2025, Wyndham Hotels & Resorts operates 846,700 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands, as of the end of 2024. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms, as of the end of 2024.